de Sousa T, Victor J
Vaccines (Basel). 2020; 8(3).
PMID: 32759782
PMC: 7564284.
DOI: 10.3390/vaccines8030436.
Edholm E, Banach M, Robert J
Immunogenetics. 2016; 68(8):525-36.
PMID: 27368412
PMC: 5695035.
DOI: 10.1007/s00251-016-0929-7.
Ingulli E
Pediatr Nephrol. 2011; 25(1):61-74.
PMID: 21476231
PMC: 2778785.
DOI: 10.1007/s00467-008-1020-x.
Mester G, Hoffmann V, Stevanovic S
Cell Mol Life Sci. 2011; 68(9):1521-32.
PMID: 21387142
PMC: 11114492.
DOI: 10.1007/s00018-011-0659-9.
Racape J, Connan F, Hoebeke J, Choppin J, Guillet J
Proc Natl Acad Sci U S A. 2006; 103(48):18208-13.
PMID: 17116886
PMC: 1654130.
DOI: 10.1073/pnas.0609029103.
Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes.
Rotzschke O, Falk K, Mack J, Lau J, Jung G, Strominger J
Proc Natl Acad Sci U S A. 1999; 96(13):7445-50.
PMID: 10377434
PMC: 22105.
DOI: 10.1073/pnas.96.13.7445.
Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.
Chervonsky A, Medzhitov R, Denzin L, Barlow A, Rudensky A, Janeway Jr C
Proc Natl Acad Sci U S A. 1998; 95(17):10094-9.
PMID: 9707606
PMC: 21467.
DOI: 10.1073/pnas.95.17.10094.
Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system.
Smith K, Kurago Z, Lutz C
Immunol Res. 1997; 16(3):243-59.
PMID: 9379075
DOI: 10.1007/BF02786393.
On the calculation of binding free energies using continuum methods: application to MHC class I protein-peptide interactions.
Froloff N, Windemuth A, Honig B
Protein Sci. 1997; 6(6):1293-301.
PMID: 9194189
PMC: 2143728.
DOI: 10.1002/pro.5560060617.
Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).
Smith P, Brunmark A, Jackson M, POTTER T
J Exp Med. 1997; 185(6):1023-33.
PMID: 9091576
PMC: 2196245.
DOI: 10.1084/jem.185.6.1023.
The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.
Orihuela M, Margulies D, Yokoyama W
Proc Natl Acad Sci U S A. 1996; 93(21):11792-7.
PMID: 8876216
PMC: 38137.
DOI: 10.1073/pnas.93.21.11792.
Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.
Solheim J, Cook J, Hansen T
Immunol Res. 1995; 14(3):200-17.
PMID: 8778210
DOI: 10.1007/BF02918217.
MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains.
Suh W, Mitchell E, Yang Y, Peterson P, Waneck G, Williams D
J Exp Med. 1996; 184(2):337-48.
PMID: 8760787
PMC: 2192707.
DOI: 10.1084/jem.184.2.337.
A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.
Huang F, Hermann E, Wang J, Cheng X, Tsai W, Wen J
Infect Immun. 1996; 64(1):120-7.
PMID: 8557329
PMC: 173736.
DOI: 10.1128/iai.64.1.120-127.1996.
Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
Fu Y, Nathan D, Li F, Li X, Faustman D
J Clin Invest. 1993; 91(5):2301-7.
PMID: 8486790
PMC: 288235.
DOI: 10.1172/JCI116459.
Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides.
Sherman L, Chattopadhyay S, Biggs J, Dick 2nd R, Bluestone J
Proc Natl Acad Sci U S A. 1993; 90(15):6949-51.
PMID: 8346201
PMC: 47052.
DOI: 10.1073/pnas.90.15.6949.
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
Dal Porto J, Johansen T, Catipovic B, Parfiit D, Tuveson D, Gether U
Proc Natl Acad Sci U S A. 1993; 90(14):6671-5.
PMID: 8341685
PMC: 46994.
DOI: 10.1073/pnas.90.14.6671.
Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera.
Vyas J, Rich R, Howell D, Shawar S, Rodgers J
J Exp Med. 1994; 179(1):155-65.
PMID: 8270862
PMC: 2191314.
DOI: 10.1084/jem.179.1.155.
Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide.
Neefjes J, Hammerling G, Momburg F
J Exp Med. 1993; 178(6):1971-80.
PMID: 8245776
PMC: 2191294.
DOI: 10.1084/jem.178.6.1971.
H-2Dd exploits a four residue peptide binding motif.
Corr M, Boyd L, Padlan E, Margulies D
J Exp Med. 1993; 178(6):1877-92.
PMID: 8245770
PMC: 2191296.
DOI: 10.1084/jem.178.6.1877.